Pier 88 Investment Partners LLC Crispr Therapeutics Ag Transaction History

Pier 88 Investment Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $138,294 - $206,024	-2,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $340,987 - $541,425	-4,865 Reduced 65.17%	2,600 $197,000
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $40,774 - $57,956	370 Added 5.21%	7,465 $835,000
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $433,612 - $696,126	4,300 Added 153.85%	7,095 $1.15 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $438,185 - $952,765	-5,500 Reduced 66.31%	2,795 $1.57 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $969,632 - $1.24 Million	-12,352 Reduced 59.82%	8,295 $694,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $397,204 - $784,607	10,317 Added 99.87%	20,647 $1.52 Million
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $296,047 - $549,638	8,790 Added 570.78%	10,330 $438,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $56,487 - $112,620	1,540 New	1,540 $94,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Pier 88 Investment Partners LLC with notifications on news.